The IPV (Injectable Polio Vaccine) is one of the safest vaccines to use and is required to eliminate the risk of further existence of Polio. This is being launched at a time when no polio cases are reported in India during the last four years and at a time when India is switching from Oral Polio Vaccine (OPV) to IPV.
Made in Telangana Polio vaccine launched
Oral Polio Vaccine has a 1 per cent of failure risk whereas IPV is considered to be without any risk. KCR launched the vaccine handed over the first sample of five doses pack to the representative of UNICEF.
The chairman of the Shantha Biotechnics Varaprasad Reddy informed though IPVs are priced at Rs 1,050 per unit in the international market, Shantha Biotechnics will be supplying to UNICEF and Government of India at Rs 55 only.
After this is launched, Indian Government will supply IPV manufactured by Shantha to the entire country through UNICEF. Telangana will get this from UNICEF at free of cost. IPV is effective in preventing paralytic disease caused by all three types of polio virus and carries no risk of vaccine associated risks.
Manufacturing of SHAN-IPV is a pride for Telangana State said KCR. UNICEF has already indented for 2.5 million doses of this vaccine and will be supplying to both the Telugu speaking states free of cost.
Government of India also indented for this vaccine. Both Government of India and UNICEF decided to use this vaccine as part of total eradication of polio. Shantha plans to produce a total of more than 10 million doses next year with additional increases planned in subsequent years.
Shailesh Ayyangar, MD- India and VP South Asia, Sanofi commenting on the launch said, “Today, we are proud to further strengthen our commitment towards disease prevention and support the Indian government’s Universal Immunisation Programme – including polio eradication.”
Pakistan and Afghanistan are still classified as polio endemic, meaning that wild polio virus passes routinely between members of the community. However, progress has been made in both countries and the last case of polio in the world may possibly be only months away. India has had a strong focus on polio eradication and this move to introduce IPV in the UIP will provide the required impetus for a polio free India.
In line with the WHO’s Global endgame strategy, India is introducing one dose of IPV at 14 weeks of age. IPV is to be given in addition to the existing oral polio vaccine. This introduction is a critical step towards achieving a polio-free world by 2019 to meet the Global Polio Eradication Initiative (GPEI) Endgame Strategic Plan.